plerixafor has been researched along with Hyperplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alkhatib, B; David, N; Fréguin-Bouilland, C; Godin, M; Henry, JP; Lallemand, F; Plissonnier, D; Thuillez, C | 1 |
1 other study(ies) available for plerixafor and Hyperplasia
Article | Year |
---|---|
Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting.
Topics: Animals; Aorta; Arteriosclerosis; Benzylamines; Chemokine CXCL12; Chemokines, CXC; Cyclams; Endothelium, Vascular; Heterocyclic Compounds; Hyperplasia; Male; Molecular Weight; Polysaccharides; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Receptors, CXCR4; Transplantation; Transplantation, Homologous; Tunica Intima | 2007 |